Institute of Pathology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chronic hearing loss turns out being a calcified chondroid mesenchymal neoplasm with FN1::FGFR2 fusion (2024) Bauerschmitz L, Agaimy A, Eckstein M, Balk M, Iro H, Schleder S, Schlaffer SM, Gostian AO Journal article Pre-treatment metastatic biopsy: a step towards precision oncology for urothelial cancer (2024) Klümper N, Cox A, Sjödahl G, Roghmann F, Bolenz C, Hartmann A, Grünwald V, et al. Journal article, Review article Harnblase: Tumorvorstufen und nichtinvasive Karzinome (2024) Lange F, Hartmann A, Eckstein M Journal article Smartwatch, hemorrhagic pericardial effusion and acute kidney injury—all united in one diagnosis Smartwatch, hämorrhagischer Perikarderguss und akute Nierenschädigung – alle vereint eine Diagnose (2024) Neumann LM, Baumgärtel MW, Amann KU, Friesicke H Journal article Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites (2024) Agaimy A, Blakely M, Breimer GE, Hölsken A, Koppes SA, Meidenbauer N, Rijken JA, et al. Journal article Conventional (bone-type) giant cell tumor of the larynx: the first case with proven H3-3A: c.103G >T (p.Gly35Trp) mutation (2024) Laco J, Vosmikova H, Satankova J, Dedkova J, Mejzlik J, Chrobok V, Agaimy A Journal article Molekulare Testung bei mesenchymalen Neoplasien: Was, wann und wie testen? Eine Übersicht mit besonderem Fokus auf den Stellenwert der Next-Generation-Immunhistochemie als Alternative für molekulare Testung (2024) Agaimy A Journal article Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers (2024) Hanf D, Fasching P, Gaß P, Beckmann M, Hack C, Heindl F, Häberle L, et al. Journal article Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab. (2024) Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, et al. Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article